Asischem Inc

Alkermes is a worldwide pharmaceutical company that develops controlled, sustained-release injectable drugs using with its trademark ProLease and Medisorb technologies. Located in Massachusetts, the company also develops inhaled formulations from its proprietary pulmonary technology. Alkermes has partnered with Johnson & Johnson to develop Riserpdal Consta, an antipsychotic drug used in the treatment of schizophrenia. Risperdal Consta is approved for sale in more than 50 countries that include the United States, United Kingdom and Germany. In addition to a host of partnered products, the ocmpany is also active in the development of several promising proprietary products, such as Vivitrex, a long-acting injectable form of naltrexone for alcohol dependence. Alkermes is headquartered in Cambridge, Mass.

Aviceda Therapeutics, based in Cambridge, MA, focuses on harnessing the body's natural immune system to modulate inflammation. The company utilizes highly selective ligands designed for maximum specificity towards targeted immune cells and diseases. By employing nature's design, Aviceda Therapeutics aims to develop innovative therapeutic solutions that enhance immune responses. Their approach emphasizes precision in targeting, which is crucial for effectively addressing various health conditions. Generated from the website

Biomodels in Waltham offers a wide range of preclinical research services, specializing in contract services for biopharmaceutical companies. Their experienced team provides comprehensive preclinical CRO services to support the development of innovative therapies and drug candidates. Generated from their website's infomation